BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:39 PM
 | 
Sep 05, 2012
 |  BC Extra  |  Company News

ImmuNext, J&J in cancer deal

ImmuNext Inc. (Lebanon, N.H.) granted Johnson & Johnson (NYSE:JNJ) exclusive, worldwide rights to develop and commercialize products that antagonize the V-region immunoglobulin-containing suppressor of T...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >